Protagenic Therapeutics, Inc.\new
PTIX· OTC
PTIXProtagenic Therapeutics, Inc.\new
Filed Mar 29, 2019 · 10-K · 88 days after period end · 0001493152-19-004288
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$790.45K | -$696.12K | -$556.08K | -$158.00K |
| EPS Diluted | — | — | — |
Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end
